维百奥(北京)生物科技有限公司

400-001-2615
info@vicbio.com
产品名称 Seraseq® ctDNA Reference Material v2 AF0.5%(SeraCare)
目录号 0710-0205
别名 N/A
外观 N/A
分子量 N/A
CAS N/A
溶解度 N/A
存储条件 N/A
保存时间 N/A
备注1 N/A
备注2 N/A
目录号 规格 价格 库存状态  
0710-0205 1 x 5 mL 咨询客服 咨询客服

品名:Seraseq® ctDNA Reference Material v2 AF0.5%

货号:0710-0205

品牌:SeraCare 


Product Specifications 

# of Variants:40 

Allele Frequency:0.5% 

Fragment Size:~170bp  average 

Concentration:25 ng/mL 

Volume:5 mL 

Total DNA:125 ng (single vial) 

Matrix:SeraCon™ Matribase (human plasma-like) 

1705979143339286.png

1705979173609585.png

Archer® is a registered trademark, and Reveal ctDNA™ is a trademark of ArcherDx, Inc. 

Oncomine® is a registered trademark of Thermo Fisher Scientific. 

UltraSEEK™ is a trademark of Agena Bioscience, Inc.


Details

To overcome the lack of patient-like reference materials for liquid biopsy, including drawbacks of existing 

methodologies such as sonication, SeraCare has developed a breakthrough technology that produces the 

most patient-like materials compared to native ctDNA. The Seraseq ctDNA Mutation Mix v2 is a highly 

multiplexed product for NGS-based ctDNA assays targeting cancer-relevant somatic mutations. 


This specific ctDNA Reference Material v2 product has an allele frequency of 0.5%. 

      Size distribution, library yield and complexity consistent with native ctDNA 

      Single sample with 40 clinically-relevant mutations across 28 genes, all at the same specified allele frequency 

      Offered in a full-process plasma-like material capable of assessing the entire workflow from extractio

through analysis 

      Mutation targets precisely quantitated with digital PCR 

      Single well-characterized GM24385 human genomic DNA as background wild-type material 

      Manufactured in GMP-compliant and ISO 13485-certified facilities


                                                        65ab095e3a4b3.png

维百奥生物代理SeraCare对照及参比物质。


维百奥(北京)生物科技有限公司,自2018年与SeraCare(现隶属于LGC Clinical Diagnostics)合作以来,长期为中国客户

提供包括SeraSeq系列参比物质,领域包括肿瘤、生殖健康遗传病。SeraCare研发和生产一系列临床参比物质,可以用于任何

研发阶段,以确保临床基因组学检测结果的准确性。

 

SeraCare参比物质涵盖的范围:

1)Next Generation Sequencing

2)Sanger Sequencing

3)Real-time PCR and digital PCR (dPCR)

4)Microarray

 

主要特点

1)Ready-to-use reference materials covering clinically-relevant variants and all variant types - SNVs, INDELS, CNVs, 

and RNA fusions

2)Highly multiplexed - provide significantly more data per NGS run, saving sequencing costs

3)Available in multiple formats to suite different workflow needs - purified DNA & RNA, ctDNA, encapsulated ctDNA

in plasma, and FFPE

4)Manufactured in cGMP-compliant, ISO 13485-certified facilities

5)Stringent product release testing - all variants qualified by dPCR for allele frequencies or copy numbers

相关产品